Dr. Tap on Improved Overall Survival With Olaratumab/Doxorubicin Combination OncLive 0:49 9 years ago 445 Далее Скачать
What are Progression Free Survival (PFS) and Overall Survival (OS)? HealthTree University for Multiple Myeloma 2:16 4 years ago 5 357 Далее Скачать
Overall vs. Progression-Free Survival, Response Rates: Oncology Terminology 101 (by Oster Oncology) Oster Oncology 10:30 5 years ago 7 651 Далее Скачать
Practical Implications of Using Olaratumab in Patients with STS OncLive 5:23 8 years ago 323 Далее Скачать
Olaratumab Plus Doxorubicin in Advanced Soft Tissue Sarcoma Targeted Oncology 2:19 9 years ago 908 Далее Скачать
Registration Trials for Olaratumab and Doxorubicin for STS OncLive 8:00 8 years ago 188 Далее Скачать
The Impact and Long-Term Potential of Olaratumab in Soft Tissue Sarcoma OncLive 1:34 7 years ago 563 Далее Скачать
Dr. Tap on Olaratumab in Patients With Soft Tissue Sarcoma OncLive 1:17 8 years ago 928 Далее Скачать
Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue Sarcoma Targeted Oncology 1:13 9 years ago 1 687 Далее Скачать
Dr. Chapman 5 | Progression free survival (PFS) vs. Overall survival (OS). BeatingMelanoma 5:40 1 year ago 71 Далее Скачать
What is progression free survival (PFS) and overall survival (OS) in breast cancer? Outcomes4Me 2:11 2 years ago 803 Далее Скачать
